You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 157 No. 8, 28 APRIL 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fever, C-Reactive Protein, and Other Acute-Phase Reactants During Treatment of Infective Endocarditis

Lars Olaison, MD, PhD; Harriet Hogevik, MD, PhD; Kjell Alestig, MD, PhD

Arch Intern Med. 1997;157(8):885-892.


Abstract

Background
Fever and sustained elevations of levels of C-reactive protein, erythrocyte sedimentation rate, and other inflammatory markers are common problems during treatment of infective endocarditis. We studied the value of these measurements during an 8-year period in all episodes of infective endocarditis treated in 1 university-affiliated institution.

Methods
A total of 193 consecutive episodes that fulfilled the criteria for infective endocarditis were prospectively enrolled during 2 periods, 1984 through 1988 and 1993 through 1995. Fever and results of serial measurements of C-reactive protein, erythrocyte sedimentation rate, white blood cell counts, and platelet counts were related to the clinical course of infective endocarditis.

Results
Fever persisted or recurred in 108 episodes (57%) despite appropriate antibiotic treatment. The causes of persistent fever and recurrent fever were different. Persistent fever that lasted 7 days or longer was caused by a

complicating cardiac infection in 56% of these episodes. Recurrent fever, noted in 31% of all episodes and the major cause of fever during the third and fourth treatment weeks, was caused most often by hypersensitivity reactions to β-lactams. Elevations in C-reactive protein levels were significantly prolonged in the episodes with complicated courses compared with the episodes with uncomplicated courses, while mean erythrocyte sedimentation rate remained unchanged during treatment, not differentiating between complicated and uncomplicated episodes.

Conclusions
Fever during treatment must be analyzed in terms of persistence and recurrence to provide a basis for clinical decisions. Serial measurements of Creactive protein are useful to monitor the reponse to antimicrobial therapy and to detect complications, while serial determinations of erythrocyte sedimentation rate are of no value.

Arch Intern Med. 1997;157:885-892



Author Affiliations

From the Department of Infectious Diseases, Göteborg University, Göteborg, Sweden.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lipopolysaccharide-Binding Protein: A New Biomarker for Infectious Endocarditis?
Vollmer et al.
Clin. Chem. 2009;55:295-304.
ABSTRACT | FULL TEXT  

Prognostic Value of Serial C-Reactive Protein Measurements in Left-Sided Native Valve Endocarditis
Verhagen et al.
Arch Intern Med 2008;168:302-307.
ABSTRACT | FULL TEXT  

Antimicrobial treatment of infective endocarditis caused by viridans streptococci highly susceptible to penicillin: historic overview and future considerations
Verhagen et al.
J Antimicrob Chemother 2006;57:819-824.
ABSTRACT | FULL TEXT  

Utility of serum C-reactive protein in assessing the outcome of infective endocarditis
Heiro et al.
Eur Heart J 2005;26:1873-1881.
ABSTRACT | FULL TEXT  

Incidence of {beta}-Lactam-Induced Delayed Hypersensitivity and Neutropenia During Treatment of Infective Endocarditis
Olaison et al.
Arch Intern Med 1999;159:607-615.
ABSTRACT | FULL TEXT  

C-Reactive Protein—Undervalued, Underutilized
Gambino
Clin. Chem. 1997;43:2017-2018.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.